Transgene Biotek Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 0.550847 million. Revenue was INR 0.989317 million compared to INR 0.43847 million a year ago.

Net loss was INR 13.88 million compared to INR 26.11 million a year ago. Basic loss per share from continuing operations was INR 0.18 compared to INR 0.34 a year ago. Diluted loss per share from continuing operations was INR 0.18 compared to INR 0.34 a year ago.